Bridgewest Perth Pharma gains strategic edge with noted Australian Executive John Van Der Wielen on Board
- Written by PR Newswire
![]() |
PERTH, Australia, July 2, 2024 /PRNewswire/ -- Bridgewest Perth Pharma, global pharmaceutical holding company with NovaCina CDMO division and LumaCina pharmaceutical supply division, announces the addition of renown Australian executive John Van Der Wielen to Board of Directors. Van Der Wielen will focus on Australian expansion...








